NCT03269435View on ClinicalTrials.gov

Greater Occipital Nerve Block Versus Metoclopramide

PHASE4CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

March 21, 2020

Study Completion Date

March 21, 2020

Conditions
Migraine
Interventions
PROCEDURE

Greater occipital nerve block with bupivacaine

This is a type of peripheral nerve block. 3cc of 0.5% bupivacaine will be injected adjacent to the greater occipital nerve block blaterally

DRUG

Metoclopramide

Metoclopramide 10mg IV will be administered over 15 minutes

Trial Locations (1)

10467

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT03269435 - Greater Occipital Nerve Block Versus Metoclopramide | Biotech Hunter | Biotech Hunter